309. Progressive myoclonus epilepsy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 16 / Drugs : 26 - (DrugBank : 5) / Drug target genes : 6 - Drug target pathways : 14
| Other names | Progressive myoclonic epilepsy; | ||
|---|---|---|---|
| Disease group | Neuromuscular diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
52 patients Age distribution
 💬 |
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 309-01, 309-02, 309-03 | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | - | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 309-1. | Unverricht-Lundborg disease; | 11-29-83. Unverricht-Lundborg disease | |
| 309-2. | Lafora disease; | 11-29-84. Lafora disease | |
| 309-3. | Benign adult familial myoclonus epilepsy;BAFME; | ||